Pharmacology letters Accelerated communicationInfluence of diabetes on norepinephrine-induced inositol 1,4,5-trisphosphate levels in rat aorta
References (14)
- et al.
Eur. J. Pharmacol.
(1988) Life Sci.
(1989)- et al.
Biochem. Biophys. Res. Commun.
(1987) - et al.
Trends in Pharmacol. Sci.
(1988) - et al.
Diabetes
(1985)- et al.
Br. J. Pharmacol.
(1990)
There are more references available in the full text version of this article.
Cited by (18)
The diabetic vasculature: Physiological mechanisms of dysfunction and influence of aerobic exercise training in animal models
2014, Life SciencesCitation Excerpt :A plethora of studies have reported enhanced responses to α-adrenergic agonist, such as norepinephrine and phenylephrine, in different T1DM vessels (McLeod and McNeil, 1985; Agrawal and McNeill, 1987; Kamata et al., 1988; Abebe and MacLeod, 1991a, 1991b; Taylor et al., 1994) and T2DM vessels (Khazaei et al., 2008; Brondum et al., 2008). Most of these studies related this alteration to increased inositol 1,4,5-trisphosphate (IP3) and DAG production and consequently enhanced contractile response (Abebe and MacLeod, 1991b). Moreover, the abnormal release of vasoconstrictors has been demonstrated.
Effects of taurine on the reactivity of aortas from diabetic rats
2008, Life SciencesEffects of adenosine analogs on inositol 1,4,5-trisphosphate production in porcine coronary artery
2002, Vascular PharmacologyPlatelet-activating factor-induced inositol 1,4,5-trisphosphate generation in undifferentiated and differentiated U937 cells: Role of tyrosine kinase
1996, International Journal of ImmunopharmacologyG-proteins in rat blood vessels-II. Assessment of functional involvement
1995, General Pharmacology
- ∗
Present address: Allergic Disease Center, School of Medicine, Creighton University, Omaha, NE 68178
Copyright © 1991 Published by Elsevier Inc.